The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
The US Food and Drug Administration (FDA) has approved the messenger RNA-based (mRNA) vaccine against respiratory syncytial virus (RSV) for people ages 60 and older. The vaccine, made by ...
The US Food and Drug Administration (FDA) approved mRESVIA (mRNA-1345, Moderna), a vaccine for respiratory syncytial virus (RSV). The mRNA vaccine is approved for adults aged 60 years or ...